Altimmune
ALT
#8291
Rank
โ‚ฌ0.29 B
Marketcap
1,49ย โ‚ฌ
Share price
2.17%
Change (1 day)
-58.59%
Change (1 year)

Earnings for Altimmune (ALT)

Earnings in 2026 (TTM): -โ‚ฌ78.99 Million

According to Altimmune's latest financial reports the company's current earnings are โ‚ฌ0.03 Million. In 2025 the company made an earning of -โ‚ฌ80.54 Million, an increase over its 2024 earnings that were of -โ‚ฌ86.24 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Altimmune from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ78.99 Million-1.93%
2025 -โ‚ฌ80.54 Million-6.61%
2024 -โ‚ฌ86.24 Million7.48%
2023 -โ‚ฌ80.24 Million4.17%
2022 -โ‚ฌ77.04 Million-12.55%
2021 -โ‚ฌ88.09 Million78.27%
2020 -โ‚ฌ49.41 Million164.65%
2019 -โ‚ฌ18.67 Million-54.59%
2018 -โ‚ฌ41.12 Million-12.95%
2017 -โ‚ฌ47.24 Million-164.04%
2016 โ‚ฌ73.75 M-2506.1%
2015 -โ‚ฌ3.07 Million-65.85%
2014 -โ‚ฌ8.98 Million-15.12%
2013 -โ‚ฌ10.58 Million146.72%
2012 -โ‚ฌ4.29 Million-16.07%
2011 -โ‚ฌ5.11 Million-76.1%
2010 -โ‚ฌ21.37 Million-8.89%
2009 -โ‚ฌ23.46 Million31.17%
2008 -โ‚ฌ17.88 Million549.91%
2007 -โ‚ฌ2.76 Million7.52%
2006 -โ‚ฌ2.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.15 Billion 73.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ16.48 Million-80.21%๐Ÿ‡บ๐Ÿ‡ธ USA